ES2000491A6 - Un metodo para producir una cepa de streptococcus equi que no es virulenta para equinos - Google Patents

Un metodo para producir una cepa de streptococcus equi que no es virulenta para equinos

Info

Publication number
ES2000491A6
ES2000491A6 ES8600234A ES8600234A ES2000491A6 ES 2000491 A6 ES2000491 A6 ES 2000491A6 ES 8600234 A ES8600234 A ES 8600234A ES 8600234 A ES8600234 A ES 8600234A ES 2000491 A6 ES2000491 A6 ES 2000491A6
Authority
ES
Spain
Prior art keywords
vaccine
equi
equine
strain
nasopharyngeal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8600234A
Other languages
English (en)
Inventor
John F Timoney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Original Assignee
Cornell Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc filed Critical Cornell Research Foundation Inc
Publication of ES2000491A6 publication Critical patent/ES2000491A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/829—Bacterial vaccine for equine species, e.g. horses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

EL METODO DESCRITO COMPRENDE SOMETER A MUTAGENESIS A UNA CEPA VIRULETA DE S.EQUI Y SELECCIONAR UNA BACTERIA RESULTANTE QUE PROPORCIONA UN FRAGMENTO DE PROTEINA -M DE UN PESO MOLECULAR DE 41.000. LA CEPA MUTADA ASI OBTENIDA, S.EQUI (709-27), ES UTIL PARA PREPARAR UNA NUEVA VACUNA BACTERIANA CONTRA EL GARROTILLO EN EQUINOS, LA CUAL ESTIMULA UNA RESPUESTA DE INMUNIDAD NASOFARINGEA MEDIANTE LA PRESENCIA DE ACTIVIDAD DE ANTICUERPOS EN EL MOCO NASOFARINGEO. LA VACUNA ES ADECUADA PARA ADMINISTRACION A UN EQUINO POR VIA INTRANASAL U ORAL Y ESTIMULA UNA RESPUESTA DE ANTICUERPOS EN LA MUCOSA NASOFARINGEA DEL EQUINO SUSCEPTIBLE A S.EQUI.
ES8600234A 1985-07-12 1986-07-10 Un metodo para producir una cepa de streptococcus equi que no es virulenta para equinos Expired ES2000491A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75461385A 1985-07-12 1985-07-12

Publications (1)

Publication Number Publication Date
ES2000491A6 true ES2000491A6 (es) 1988-03-01

Family

ID=25035573

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8600234A Expired ES2000491A6 (es) 1985-07-12 1986-07-10 Un metodo para producir una cepa de streptococcus equi que no es virulenta para equinos

Country Status (18)

Country Link
US (1) US5183659A (es)
EP (1) EP0230456B1 (es)
JP (1) JPH0816064B2 (es)
AR (1) AR241545A1 (es)
AT (1) ATE71532T1 (es)
AU (1) AU604645B2 (es)
CA (1) CA1281287C (es)
DE (1) DE3683478D1 (es)
DK (1) DK167599B1 (es)
ES (1) ES2000491A6 (es)
FI (1) FI87530C (es)
GR (1) GR861795B (es)
IE (1) IE58964B1 (es)
NO (1) NO169997C (es)
NZ (1) NZ216796A (es)
PT (1) PT82971B (es)
WO (1) WO1987000436A1 (es)
ZA (1) ZA865156B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2523883Y2 (ja) * 1992-02-24 1997-01-29 株式会社三協精機製作所 プーリ付調速器
ZA97452B (en) 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
US6086894A (en) * 1996-06-27 2000-07-11 Virginia Tech Intellectual Properties, Inc. Recombinant vaccine for diseases caused by encapsulated organisms
BR9810453A (pt) 1997-06-24 2001-12-11 John F Timoney Compostos que codificam proteìna protetorasemelhante a m de streptococcus equi e testespara os mesmos
CA2243730C (en) * 1997-07-29 2009-12-22 Akzo Nobel N.V. Streptococcus equi vaccine
US20070059327A2 (en) * 1998-01-15 2007-03-15 Wyeth Streptococcus equi compositions and methods of use
DE60007668T2 (de) * 1999-01-26 2004-12-02 Akzo Nobel N.V. Verwendung lebender abgeschwächter Bakterien zur Herstellung eines submukosalen Impstoffes
AU2003269765B2 (en) 2002-10-11 2009-08-06 Intervacc Ab Immunization of non-human mammals against streptococcus equi
US20110020403A1 (en) 2007-12-13 2011-01-27 Bengt Guss immunizing composition
CN103068838B (zh) 2010-05-26 2016-03-02 英特瓦克公司 基于重组蛋白的抗链球菌感染疫苗
WO2015057777A1 (en) 2013-10-17 2015-04-23 Zoetis Llc Methods and compositions for treatment of s. equi infection
KR101694676B1 (ko) * 2015-12-10 2017-01-10 우진 비앤지 주식회사 말 선역 질병원인 국내 분리 스트렙토코커스 이콰이 균주 및 이를 포함하는 백신

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852420A (en) * 1971-01-20 1974-12-03 Richardson Merrell Inc Equine strangles vaccine and method of preparing and using the same
US3793150A (en) * 1971-01-20 1974-02-19 Richardson Merrell Inc Equine strangles vaccine and method of preparing and using the same
IL52815A (en) * 1977-08-24 1983-03-31 Israel State Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida
JPS60251898A (ja) * 1984-05-25 1985-12-12 Shiseido Co Ltd 醗酵法によるヒアルロン酸の製造方法
US4582798A (en) * 1984-11-23 1986-04-15 Miles Laboratories, Inc. Preparation and use of enzyme-detergent extracted Streptococcus equi vaccine

Also Published As

Publication number Publication date
JPS63500596A (ja) 1988-03-03
ATE71532T1 (de) 1992-02-15
FI871060A (fi) 1987-03-11
FI871060A0 (fi) 1987-03-11
US5183659A (en) 1993-02-02
PT82971A (pt) 1986-08-01
PT82971B (pt) 1988-07-01
AU604645B2 (en) 1991-01-03
FI87530C (fi) 1993-01-25
GR861795B (en) 1986-11-11
FI87530B (fi) 1992-10-15
EP0230456A4 (en) 1987-10-27
AU6149686A (en) 1987-02-10
DK125887D0 (da) 1987-03-11
DK167599B1 (da) 1993-11-29
EP0230456A1 (en) 1987-08-05
NO871012L (no) 1987-03-11
NO871012D0 (no) 1987-03-11
DK125887A (da) 1987-03-11
AR241545A1 (es) 1992-08-31
EP0230456B1 (en) 1992-01-15
NO169997B (no) 1992-05-25
ZA865156B (en) 1987-05-27
WO1987000436A1 (en) 1987-01-29
IE58964B1 (en) 1993-12-01
JPH0816064B2 (ja) 1996-02-21
NZ216796A (en) 1991-11-26
IE861852L (en) 1987-01-11
DE3683478D1 (de) 1992-02-27
CA1281287C (en) 1991-03-12
NO169997C (no) 1992-09-02

Similar Documents

Publication Publication Date Title
ES2000491A6 (es) Un metodo para producir una cepa de streptococcus equi que no es virulenta para equinos
AU7231687A (en) Computer gated positive expiratory pressure system
HUT50048A (en) Process for producing streptococcus protein antigen and pharmaceutical compositions comprising same
DE3586697D1 (en) Aktive thymopentin-analoga.
AU6424586A (en) Method for alleviation of panic disorders
ES8608872A1 (es) Un metodo para preparar una composicion terapeutica a base de un extracto soluble en piridina y una endotoxina destosificada refinada.
AU571569B2 (en) Herpes simplex vaccine
GB9814538D0 (en) Helicobacter pylori bacterioferritin
EP0302887A4 (en) ANTIGENS, ANTIBODIES, BACTERIAL VACCINES AND THEIR PRODUCTION METHOD.
JPS56106593A (en) Alkali protease m3
ATE182270T1 (de) Mukosale verabreichung von pneumokokken-antigenen
CA2148563A1 (en) Purified nontypable haemophilus influenzae p5 protein as a vaccine for nontypable haemophilus influenzae strain
AU6383296A (en) Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection
AU601415B2 (en) A process for the purification, solubilization and/or detoxification of protein antigens of bacteria of the bordetella genus using a carbonate buffer and an acellular anti-whooping cough vaccine
GB2102291B (en) Method for purifying polyosides of streptococcus pneumoniae and vaccine based on polyosides thus purified
EP0806476A3 (en) Attenuated strains of leishmania and uses thereof
EP0090660A3 (en) Neisseria gonorrhoeae vaccine
GR3005736T3 (es)
GR3036369T3 (en) Vaccines based on streptokinase.
DE68928061D1 (de) Expression von proteinsüssmitteln in hefe
FR2607392B1 (fr) Procede pour la preparation d'une souche mutante de bordetella bronchiseptica utile pour la preparation d'un vaccin vivant attenue pour la prophylaxie des infections a b. bronchiseptica et vaccin vivant attenue contre la rhinite atrophique ainsi prepare
AU3628293A (en) Hybrid DNA that codes for a subunit of a bacterial toxin with a hemolysin
Dzhidzheishvili et al. Study of the phosphatase activity of fibroblasts in the process of staphylococcal infection.
FR2589063B1 (fr) Procede de culture de babesia canis, application a la preparation d'antigenes et de vaccins, et antigenes et vaccins contre la piroplasmose
EP0309898A3 (en) Method for the induction of a cytotoxic t cell response

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20060711